By The Hill staff - 05/08/15 10:57 AM EDT
As policy leaders and regulators in Washington consider ways to accelerate the drug development process, The Hill convened a timely and thoughtful conversation on ideas and initiatives that could help spur the growth of new medicines and potential cures for ailing patients. From the 21st Century Cures initiative in the House, to companion efforts in the Senate, to ambitious public-private collaboration in the pharmaceutical space, new ideas are emerging for ways Washington can work with industry to beat both widespread and rare diseases.
The Hill examines key policy proposals aimed at speeding the drug development cycle from discovery to delivery.
8:30 AM - Keynote interview with SENATOR RICHARD BURR (R-NC)
8:45 AM - Keynote interview with SENATOR BILL CASSIDY (R-LA)
9:00 AM - PhRMA President & CEO JOHN J. CASTELLANI
9:10 AM - Discussion on collaborative efforts to speed up the drug development cycle with JEFF ALLEN, Executive Director at Friends of Cancer Research; MARGARET ANDERSON, Executive Director at FasterCures; MARC BOUTIN, CEO of National Health Council; and THERESA MULLIN, Director of the Office of Strategic Programs at the FDA's Center for Drug Evaluation and Research.